Search Results 21-30 of 1116 for B cell lymphomas

  1. Hodgkin's lymphoma (Hodgkin's disease) - Care at Mayo Clinic - Mayo Clinic

    Mayo Clinic laboratories are equipped with the advanced technology doctors need to carefully analyze your cancer cells in order to help choose the most appropriate treatment for you.

  2. Hodgkin's lymphoma (Hodgkin's disease) - Doctors and departments - Mayo Clinic

    Oncologist Hematologist Jacksonville, FL Areas of focus: Chemotherapy, CAR t-cell therapy, Cellular therapy, Immunotherapy, Bone marrow biopsy and aspiration, Hairy cell leukem ... ia, Non-Hodgkin's lymphoma...

  3. Lymphoma - Doctors and departments - Mayo Clinic

    Oncologist Hematologist Jacksonville, FL Areas of focus: Chemotherapy, CAR t-cell therapy, Cellular therapy, Immunotherapy, Bone marrow biopsy and aspiration, Hairy cell leukem ... ia, Non-Hodgkin's lymphoma...

  4. Cellular Immunotherapy for Viral Induced Cancer - EBV Positive Lymphomas - Mayo Clinic

    Study IDs Site IRB Rochester, Minnesota: 16-008918 NCT ID: NCT02763254 Sponsor Protocol Number: CM-2015-01 About this study To investigate the efficacy of autologous Epstein-barr virus (EBV)-specific T cells for the treatment of EBV ...

  5. DNA Sequencing-Based Monitoring of Minimal Residual Disease to Predict Relapse in Aggressive B-cell Non-Hodgkin Lymphomas - Mayo Clinic

    Study IDs Site IRB Rochester, Minnesota: 16-000517 NCT ID: NCT02633111 Sponsor Protocol Number: 15-180 About this study The purpose of this study is to determine whether a blood test can accurately detect whether if the participant's lymphoma...

  6. CAR-T Cell Therapy Program - About CAR-T cell therapy - Mayo Clinic

    Conditions treated CAR-T Cell Therapy Click here for an infographic to learn more The FDA-approved conditions for CAR-T cell therapy include: B-cell precursor acute lymphoblastic leukemia (ALL), in p...

  7. Axi-cel treatment for B-cell lymphoma provides real-world outcomes comparable to ZUMA-1 trial data - Mayo Clinic

    Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma.

  8. Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) - Mayo Clinic

    Identifying these genetic abnormalities first may help doctors plan better treatment for patients with solid tumors, lymphomas, or multiple myeloma.

  9. An Investigational Immuno-therapy Safety and Effectiveness Study of Nivolumab in Combination With Brentuximab Vedotin to Treat Non-Hodgkin Lymphomas - Mayo Clinic

    The subtypes we are studying are Diffuse Large B-Cell Lymphoma (DLBCL), Peripheral T-Cell Lymphoma (PTCL), Cutaneous T-Cell Lymphoma (CTCL), Primary...

  10. Oncolytic virus optimizes CAR-T cell therapy for solid tumors - Mayo Clinic

    Currently, CAR -T cell therapy products are available for the treatment of relapsed, refractory B-cell lymphoma, mantle cell lymphoma, follicular lymphoma...